Vibration and Cold for Pain Relief During Peripheral Intravenous Cannulation in Children With Intellectual Disability

Sponsor
IRCCS Burlo Garofolo (Other)
Overall Status
Completed
CT.gov ID
NCT02434731
Collaborator
(none)
71
1
2
2
35.4

Study Details

Study Description

Brief Summary

Needle procedures are the most common and important source of pain and distress in children in the health care setting. Children with intellectual disability from any cause experience pain more frequently than healthy children. They often require venipuncture or IV cannulation for diagnostic or therapeutic procedures. Pain in this population is often unrecognised because these patients are frequently unable to self-report their pain. Now it's possible to measure pain in children with intellectual disability with specific pain scales, like NCCPC-PV (Non-Communicating Children's Pain Checklist, Post-operative Version).

The efficacy of a device combining vibration and cold for pain relief during venipuncture or IV cannulation has been recently reported in children. The device's actions are based on the Gate Control Theory, whereby cold and vibrations stimulate large fiber and inhibitory neurons to interrupt nociception. This non-pharmacologic technique for pain relief could be useful in this kind of patients in emergency department. To date, there is no study that validated Buzzy device for pain relief in children with intellectual disability.

The aim of this study is to test the effectiveness of Buzzy® (a device that provides cold and vibration), in reducing the pain during venipuncture or IV cannulation, in children with intellectual disability.

Condition or Disease Intervention/Treatment Phase
  • Device: Buzzy® device
Phase 3

Study Design

Study Type:
Interventional
Actual Enrollment :
71 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Randomized Controlled Trial to Evaluate the Effectiveness of Vibration and External Cold (Buzzy Device) for Pain Relief During Venipuncture or Intravenous Cannulation in Children With Intellectual Disability.
Study Start Date :
Apr 1, 2015
Actual Primary Completion Date :
Jun 1, 2015
Actual Study Completion Date :
Jun 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Buzzy® device

The Buzzy® device will be applied just above the selected site of the venipuncture; a ice pack will be attached under the device; the device will be turned on and after 15 second the procedure will be carried out.

Device: Buzzy® device
Buzzy® is a battery-powered device for venipuncture pain relief combining cold, vibration, and distraction.

No Intervention: No intervention

No intervention for pain relief

Outcome Measures

Primary Outcome Measures

  1. Pain score (NCCPC-PV scale) [intraoperative]

    The pain during the procedure will be evaluated using the NCCPC-PV scale (Non-communicating Children's Pain Checklist - Postoperative Version) administered by a nurse

Secondary Outcome Measures

  1. Success at first attempt [intraoperative]

    Percentage of success at first attempt

  2. Number of attempts required [intraoperative]

    Total number of attempts required

  3. Adverse events [up to 15 minutes after the procedure]

    The number and the type of adverse events will be recorded

Eligibility Criteria

Criteria

Ages Eligible for Study:
4 Years to 17 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 4 to 17 years

  • Presence of intellectual disability

  • Need of peripheral IV line or venipuncture

  • Informed consent signed by parents or legal guardians

Exclusion Criteria:
  • Presence of abrasion, infection or break in skin in the area of Buzzy® placement

  • Cold hypersensibility

Contacts and Locations

Locations

Site City State Country Postal Code
1 IRCCS Burlo Garofolo Trieste Friuli Venezia Giulia Italy 34137

Sponsors and Collaborators

  • IRCCS Burlo Garofolo

Investigators

  • Study Chair: Egidio Barbi, MD, IRCCS Burlo Garofolo, Trieste, Italy
  • Study Director: Silvana Schreiber, RN, IRCCS Burlo Garofolo, Trieste, Italy
  • Principal Investigator: Giorgio Cozzi, MD, IRCCS Burlo Garofolo, Trieste, Italy

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ronfani Luca, MD, PhD, IRCCS Burlo Garofolo
ClinicalTrials.gov Identifier:
NCT02434731
Other Study ID Numbers:
  • RC 20/13
First Posted:
May 5, 2015
Last Update Posted:
Aug 6, 2015
Last Verified:
Aug 1, 2015
Keywords provided by Ronfani Luca, MD, PhD, IRCCS Burlo Garofolo
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 6, 2015